Low drug resistance to both platinum and taxane chemotherapy on anin vitrodrug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer
Published 2009 View Full Article
Published 2009 View Full Article
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now